Abstract: Embodiments relate to microparticles containing moxidectin, and a preparation method thereof. Unlike conventional heartworm prevention drugs that have a short half-life and thus require daily or monthly administration, moxidectin is continuously released for at least three months and thus the effect of preventing heartworms can be maintained for at least three months when the microparticles containing moxidectin are administered. In addition, microparticles which have a constant average diameter and a narrow diameter distribution are prepared so that initial over-release of moxidectin is prevented when the microparticles are administered, the release of the drug can be controlled to keep constant the concentration of moxidectin that is valid for at least three months, and foreign body sensation and pain can be reduced when the microparticles are applied in the form of an injection.

Abstract: Embodiments relate to microparticles containing moxidectin and a method for preparing same. Unlike conventional drugs for preventing heartworm disease, which have a short half-life and require daily or monthly administration, when the microparticles containing moxidectin are administered, moxidectin is continuously released for 3 months or longer, and thus, a heartworm disease preventive effect can be maintained. In addition, by preparing microparticles having a constant average particle diameter and a narrow diameter distribution width, even when the microparticles are administered, the initial over-release of moxidectin is prevented, and the release of the drug is controlled so that a concentration of moxidectin effective for three months or longer can be kept constant, and when the microparticles are applied as an injection, foreign body sensation and pain can be reduced.

Abstract: The present disclosure provides sustained-release microparticles comprising a biodegradable polymer and a drug, wherein the biodegradable polymer and the drug are uniformly distributed throughout the particles, and the microparticles do not show an initial excessive release of the drug, and are composed of uniform-sized particles having a particle size distribution width of 35 microns or less analyzed by a particle size analyzer and a specific surface area of the microparticles of 0.75×10?1 to 2.0×10?1 m2/g, thereby exhibiting a sustained release pattern of the drug. The injection composition comprising the drug contained in such microparticles can control the release of the drug for a selected period during injection administration to release an effective drug concentration constantly, and when formulated as an injection product, can reduce foreign body sensation and pain to the subject to enable an injection formulation with high compliance to be provided.

Abstract: The present invention relates to a method for preparing a pharmaceutical composition for preventing or treating a cognitive impairment-related disease and a pharmaceutical composition for preventing or treating a cognitive impairment-related disease prepared by the same, and the pharmaceutical composition includes microparticles including donepezil and a biodegradable polymer, and the microparticles are in a form in which donepezil is uniformly distributed in a spherical biodegradable polymer. The present invention may maintain the effect of preventing or treating the cognitive impairment-related disease for 1 month by a single injection in order to eliminate the inconvenience of having to take the composition daily, and as the present invention is prepared by maintaining the average diameters of the particles at a predetermined micrometer size, a foreign body sensation and pain during administration into a patient as an injection is reduced, thereby enabling administration as an injection to be facilitated.

Abstract: The present invention relates to a composition for subcutaneous injection, containing deoxycholic acid, and a preparation method therefor. The present invention relates to a composition for non-surgical removal of localized fat deposits, the composition being micro-particles, which comprise deoxycholic acid and a biodegradable polymer, wherein the microparticles are formed such that deoxycholic acid is evenly distributed in a spherical biodegradable polymer. According to the present invention, a lipolysis effect lasts for 1 to 3 months from a single injection, a phenomenon in which surrounding tissues are destroyed during administration is prevented, and a drug release effect can be maintained at an effective amount of adipolysis concentration.

Abstract: The present invention relates to a method for preparing a pharmaceutical composition for preventing or treating a cognitive impairment-related disease and a pharmaceutical composition for preventing or treating a cognitive impairment-related disease prepared by the same, and the pharmaceutical composition includes microparticles including donepezil and a biodegradable polymer, and the microparticles are in a form in which donepezil is uniformly distributed in a spherical biodegradable polymer. The present invention may maintain the effect of preventing or treating the cognitive impairment-related disease for 1 month by a single injection in order to eliminate the inconvenience of having to take the composition daily, and as the present invention is prepared by maintaining the average diameters of the particles at a predetermined micrometer size, a foreign body sensation and pain during administration into a patient as an injection is reduced, thereby enabling administration as an injection to be facilitated.

Abstract: A method for setting a laser power of an optical disc drive is provided. To perform a label-printing operation on a label surface of an optical disc, an optical pickup unit is shifted to a control feature zone of the label surface, and a laser power operation is performed prior to initiating label printing using power setup data and sensitivity related to an internal laser diode sensor of the optical pickup unit detected during manufacture of the optical disc drive. Alternatively, power setup data associated both a data surface and a label surface of the optical disc may be detected and stored during manufacture of the optical disc drive, and a laser power of predetermined magnitude may determined based on the power setup data previously stored in association with the seated surface of the optical disc. The power setup data may be represented by a substantially linear equation relating the input voltage to the output laser power.

Abstract: An apparatus and method for controlling a broadcast channel using position information of a mobile terminal. The broadcast channel control apparatus maintains a radio or TV broadcast channel currently broadcast to a user who is in motion when the same broadcast channel as the radio or TV broadcast channel is broadcast to a plurality of areas at different broadcast frequencies.

Abstract: The present invention relates to a process for preparing polymeric particles which is specially designed to be served as an opacifying agent in coating compositions such as water-borne paints, paper coating compositions and molding compositions which have white or light color shades. In more detailed description, this invention is concerned with the process for making an aqueous dispersion of core-shell emulsion polymer particles comprising (1) preparing the core by polymerizing carboxylic acid monomers with other monoethylenically unsaturated monomers, (2) encapsulating said core with a rigid polymer shell by polymerizing shell-forming monomers, in the presence of said core particles, which are fed in such manner that compositional contents of monomers entering to a polymerization zone is changing gradually thoughout the period of monomer feeding, and (3) neutralizing with base so as to swell said core and form particles which, when dried, contain at least one void.